Reports for STERIMAX INC
Company Name
STERIMAX INC
Totals |
||
Shortage reports |
118 |
|
| Actual shortage: | 16 (14%) | |
| Anticipated shortage: | 4 (3%) | |
| Avoided shortage: | 2 (2%) | |
| Resolved: | 96 (81%) | |
Discontinuation Reports |
5 |
|
| To be discontinued: | 5 (100%) | |
| Discontinued: | 0 (0%) | |
| Reversed: | 0 (0%) | |
Late reports |
28 (23%) |
|
Overdue reports |
4 (16%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| KETOTIFEN OPHTHALMIC SOLUTION | 0.25MG | SOLUTION | Resolved | 2017-06-15 | 2017-08-15 | 12797 |
| KETOTIFEN OPHTHALMIC SOLUTION | 0.25MG | SOLUTION | Resolved | 2019-03-15 | 2019-07-02 | 78723 |
| GLYCOPYRROLATE INJECTION USP | 0.2MG | SOLUTION | Resolved | 2022-09-14 | 2023-01-19 | 169242 |
| GLYCOPYRROLATE INJECTION USP | 0.2MG | SOLUTION | Resolved | 2023-08-01 | 2023-09-30 | 200632 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 0.375G 3.000G | POWDER FOR SOLUTION | Resolved | 2024-03-07 | 2024-04-05 | 221595 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 0.375G 3.000G | POWDER FOR SOLUTION | Actual shortage | 2024-05-03 | 2024-05-03 | 227019 |
| GLYCOPYRROLATE INJECTION USP | 0.4MG | SOLUTION | Resolved | 2023-01-19 | 2023-04-17 | 181847 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 0.5G 4.0G | POWDER FOR SOLUTION | Actual shortage | 2024-05-03 | 2024-05-03 | 227022 |
| BACLOFEN INJECTION | 0.5MG | SOLUTION | Resolved | 2017-09-15 | 2017-09-20 | 22147 |
| MORPHINE SULFATE INJECTION EPIDURAL | 0.5MG | SOLUTION | Resolved | 2023-02-23 | 2023-05-23 | 185528 |
| MORPHINE SULFATE INJECTION EPIDURAL | 0.5MG | SOLUTION | Resolved | 2023-07-06 | 2023-07-29 | 197750 |
| TOBRAMYCIN FOR INJECTION USP | 1.2G | POWDER FOR SOLUTION | Actual shortage | 2018-02-07 | 2019-03-29 | 39011 |
| CYANOCOBALAMIN INJECTION USP | 1000MCG | SOLUTION | Resolved | 2023-03-03 | 2023-03-29 | 186103 |
| FENTANYL INJECTION BP | 100MCG | SOLUTION | Resolved | 2022-05-17 | 2022-11-04 | 160700 |
| TRANEXAMIC ACID INJECTION BP | 100MG | SOLUTION | Resolved | 2020-03-31 | 2020-04-07 | 110237 |
| TRANEXAMIC ACID INJECTION BP | 100MG | SOLUTION | Resolved | 2020-03-31 | 2020-04-07 | 110241 |
| TRANEXAMIC ACID INJECTION BP | 100MG | SOLUTION | Actual shortage | 2020-04-20 | 2020-09-09 | 112544 |
| TRANEXAMIC ACID INJECTION BP | 100MG | SOLUTION | Resolved | 2020-06-23 | 2020-07-03 | 118676 |
| TRANEXAMIC ACID INJECTION BP | 100MG | SOLUTION | Actual shortage | 2020-07-22 | 2020-09-09 | 120764 |
| TRANEXAMIC ACID INJECTION BP | 100MG | SOLUTION | Actual shortage | 2020-10-28 | 2020-10-29 | 127356 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PHENYLEPHRINE HYDROCHLORIDE INJECTION USP | 10MG | SOLUTION | To be discontinued | 2024-03-22 | 2024-03-22 | 223140 |
| PHENYLEPHRINE HYDROCHLORIDE INJECTION USP | 10MG | SOLUTION | To be discontinued | 2024-03-22 | 2024-03-22 | 223145 |
| STREPTOMYCIN FOR INJECTION USP | 1G | POWDER FOR SOLUTION | To be discontinued | 2023-11-06 | 2023-11-06 | 209235 |
| MYCOPHENOLATE MOFETIL FOR INJECTION USP | 500MG | POWDER FOR SOLUTION | To be discontinued | 2024-01-22 | 2024-02-06 | 216963 |
| BUPIVACAINE HYDROCHLORIDE INJECTION, USP | 7.5MG | SOLUTION | To be discontinued | 2024-01-15 | 2024-01-15 | 216017 |
Showing 1 to 5 of 5